clinical trial · NCT05590793
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Ipsen·phase3·completed·n = 195
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate CancerTriptorelin pamoate (embonate) salt
brief summary
The main aim of this study is to assess the effectiveness and safety of the 6-month formulation of triptorelin pamoate in Chinese participants with locally advanced or metastatic cancer of the prostate. Participants will receive 1 injection of triptorelin pamoate 6-month formulation.
started
Nov 17, 2022
primary completion
Aug 20, 2024
completion
Aug 20, 2024
last updated
Sep 9, 2025
official title
A Multicentre, Open-label, Single-arm Study to Investigate the Efficacy and Safety of Triptorelin Pamoate 22.5 mg 6-month Formulation in Chinese Patients With Locally Advanced or Metastatic Prostate Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol